In this regard, the identification of RACK1 as a possible EDC target in the immune context and, at the same time, its importance in tumour progression may indicate that RACK1 could play a dual role in BC- and PC-associated TME establishment and in modification of the immune response, particularly related to xeno-oestrogenic EDCs. Here, RACK1 is linked to neoplasm.